Monday 3 January 2022
myNEO will attend job fairs and participate in the following events this year provided that the Covid-19 regulations will allow for these events to t…
read more
Tuesday 21 June 2022
myNEO aims this year to double the team in size due to our growing project portfolio with multiple different partners. The data scientist team has be…
Wednesday 25 May 2022
CureVac (Nasdaq: CVAC) and myNEO will partner to identify novel targets for mRNA-based cancer vaccine development. We’re convinced that combining …
Tuesday 3 May 2022
Abera Bioscience, a listed Swedish company with vaccine platforms for prophylactic and therapeutic vaccines today signed an agreement with Belgian co…
Tuesday 15 March 2022
Opgeven Is Geen Optie (OIGO) is organising an info session on March 24th where Lien Lybaert will explain in understandable language to cancer patient…
Tuesday 2 November 2021
EIT Health Catapult provides investors and industry representatives an excellent opportunity to gain access to a concentrated elite group of top Euro…
Wednesday 20 October 2021
The biotech industry in Ghent is very much alive. This is also proven by myNEO a young company that develops technology for personalised cancer treat…
Wednesday 6 October 2021
myNEO has been nominated for the 2021 Rising Star award, together with 9 other innovative companies! The Rising Star selection is part of the Del…
Monday 4 October 2021
Proud to see that our newest developments are well acknowledged in the scientific community! myNEO will be presenting our recent research at 4 confer…
Monday 20 September 2021
To allow further growth, myNEO has moved to new offices! You can find us here: Ottergemsesteenweg 439, Ghent. Welcome to come by and visit us!
Tuesday 7 September 2021
Lore Van Oudenhove and Lena Pfitzer, both excellent principal Data Scientists at myNEO, will present their research at the ImmunoTherapy for Cancer C…
Monday 26 July 2021
The partners have received a VLAIO grant to drive innovation in neoantigen identification and validation for personalised T-cell immunotherapy The…
Tuesday 6 July 2021
The entrepreneurship world cup, organised by VOKA and GEN-Global, is an international competition for pre-starters, starters, and scalers. The compet…
Monday 17 May 2021
In an ongoing collaboration between myNEO and Radboud University Medical Center, novel neoantigens arising from non-coding regions are being investig…
Monday 3 May 2021
myNEO will be present at the 18th CIMT Annual Meeting, Europe's largest specialty meeting on cancer immunotherapy research, translation, and developm…
Wednesday 7 April 2021
Fighting Cancer with Personalised Vaccines: ONCODNA and myNEO collaboration Read the recent press release here in Dutch, French or English. Onc…
Monday 22 March 2021
Join us at Innovation for Health (April 15-16)! Cedric Bogaert will give a presentation in the AI & Digital Health session (10.15am-11.15am) on how …
Thursday 11 March 2021
myNEO announced in May 2020 the identification of promising immunogenic covid-19 peptides by making smart use of its computational algorithms which r…
Tuesday 9 March 2021
myNEO was recently selected as one of the finalists of the Computable Awards 2021 Tech Startup of the Year award. Computable awards selected for t…
Sunday 17 January 2021
Ghent, Belgium, 4 November 2020 – myNEO, a developer of personalised therapeutics using the patient’s tumour-specific alterations, today announced th…